Enhancing Incretin Action for the Treatment of Type 2 Diabetes
Daniel J. Drucker(University of Toronto)
Cited by 578
Related Papers
The role of gut hormones in glucose homeostasis
|Journal of Clinical Investigation|2007|611
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
|Endocrine Reviews|2014|602
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
|Endocrine Reviews|2020|268
Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation
|Cell Metabolism|2023|251
Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis
|American Journal of Physiology-Endocrinology and Metabolism|1999|178